Premium
RESULTS OF a MULTICENTRE UK‐WIDE STUDY EVALUATING THE EFFICACY OF BRENTUXIMAB VEDOTIN IN RELAPSED, REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN THE PRE‐TRANSPLANT NAÏVE SETTING
Author(s) -
Eyre T.A.,
Phillips E.H.,
Linton K.M.,
Kassam S.,
Gibb A.,
Allibone S.,
Peggs K.,
Burton C.,
Stewart G.,
Ledieu R.,
Booth C.,
Osborne W.,
Miall F.,
Eyre D.W.,
Ardeshna K.,
Collins G.P.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_70
Subject(s) - brentuximab vedotin , medicine , refractory (planetary science) , oncology , anaplastic large cell lymphoma , surgery , chemotherapy , gastroenterology , lymphoma , cd30 , physics , astrobiology